Chronic inducible urticaria (CIU) is a a challenging dermatological condition characterized by frequent hives triggered by specific stimuli. The global market for CIU treatments is projected to witness rapid growth over the upcoming few years, driven by influences such as growing prevalence of CIU, enhanced diagnostic capabilities, and innovations